V. Lozano

Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain

G. Nocea, A. Valladares, S. Grau, 2014, ClinicoEconomics and outcomes research : CEOR.

Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B

M. Buti, I. Oyagüez, M. Casado, 2012, PharmacoEconomics.

Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis

G. Nocea, A. Valladares, S. Grau, 2015, Applied Health Economics and Health Policy.

Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study

E. Bouza, M. Salavert, E. Obi, 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Surgical Treatment of Pressure Ulcers with a Fibrin Sealant in Patients with Spinal Cord Injury: A Cost-Consequence Analysis

I. Oyagüez, M. Casado, V. Lozano, 2015, Advances in skin & wound care.

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

I. Oyagüez, M. Casado, A. Payeras, 2012, Health Economics Review.

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCAs) were stopped, versus continuation with FDCAs

I. Oyagüez, M. Casado, F. Homar, 2012 .

Clinicoeconomics and Outcomes Research Dovepress Antibiotic Expected Effectiveness and Cost under Real Life Microbiology: Evaluation of Ertapenem and Ceftriaxone in the Treatment of Community- Acquired Pneumonia for Elderly Patients in Spain

G. Nocea, A. Valladares, S. Grau, 2022 .